These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7429993)

  • 1. The structure of mepartricin A and mepartricin B.
    Golik J; Zieliński J; Borowski E
    J Antibiot (Tokyo); 1980 Aug; 33(8):904-7. PubMed ID: 7429993
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of mobile phase pH on liquid chromatography retention of mepartricin related compounds and impurities as support to the structural investigation by liquid chromatography-mass spectrometry.
    Tengattini S; Rimaroli C; Galmozzi MR; Furlanetto S; Massolini G; Temporini C
    J Pharm Biomed Anal; 2022 Oct; 220():114971. PubMed ID: 35970110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the activity of mepartricin and amphotericin B against yeasts.
    Petrou MA; Rogers TR
    J Antimicrob Chemother; 1985 Aug; 16(2):169-77. PubMed ID: 3905747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mepartricin, a polyene active on both Trichomonas and Candida. Lack of mutagenic activity.
    Ruozi P; Siccardi AG
    Farmaco Sci; 1978 Jan; 33(1):21-5. PubMed ID: 340260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipertrofan Revisited-The Proposal of the Complete Stereochemistry of Mepartricin A and B.
    Szczeblewski P; Andrałojć W; Polit J; Żabka A; Winnicki K; Laskowski T
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinico-experimental correlation of the hypolipemic effects of mepartricin].
    Eandi M; Ruozi P; Granata F; Ricci-Gamalero S
    Arch Sci Med (Torino); 1979; 136(4):603-6. PubMed ID: 550761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic usefulness of mepartricin in benign prostatic hypertrophy: 2 years' experience. Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy].
    Mirone V; Prezioso D; Palmieri A; Bocchini P
    Minerva Urol Nefrol; 1988; 40(2 Suppl):16-7. PubMed ID: 2460938
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of the polyene antibiotic mepartricin on polymorphonuclear leucocyte function: an in-vitro study.
    Sacchi FT; Clivio A; Ferrari FA; Pagani A; Ruozi P; Siccardi AG
    J Med Microbiol; 1979 Feb; 12(1):143-6. PubMed ID: 430544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antimycoplasmal activity of mepartricin.
    Meloni GA; Busolo F; Bortolon P; Ruozi P
    Farmaco Sci; 1979 Mar; 34(3):183-8. PubMed ID: 118890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the plasma pattern of sex steroids in patients with liver cirrhosis treated with mepartricin.
    Tavanti A; Delle Monache M; Ulissi A; Del Vecchio S; Rapocci MA; Ruozi P; De Bernardi M; Ricci GL
    J Int Med Res; 1989; 17(3):212-7. PubMed ID: 2504629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Short-term treatment of vaginal trichomoniasis and moniliasis. Clinical trial of a soluble complex of mepartricin].
    Da Bormida G; Faggiolo G; Galluzzi M
    Arch Sci Med (Torino); 1978; 135(4):603-7. PubMed ID: 756721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mepartricin in prostatic hypertrophy. Results in 20 cases].
    Durval A; Rovereto B; Tosto A; Paoletti MC; Natali A; Pellegrini GL
    Minerva Urol Nefrol; 1986; 38(1):81-5. PubMed ID: 2426804
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of mepartricin on prostatic adenoma].
    Pellet B; Granata F; von Niederhäusern W
    Rev Med Suisse Romande; 1980 Nov; 100(11):899-903. PubMed ID: 6162182
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of mepartricin in the medical treatment of benign prostatic adenoma].
    Casella G; Barbaro A
    Arch Sci Med (Torino); 1978; 135(1):95-8. PubMed ID: 76466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experience with mepartricin in the treatment of prostatic hypertrophy. Preliminary results].
    Bassi P; Oliva G; Tasca A; Aragona F; Milani C; Zattoni F
    Minerva Urol Nefrol; 1988; 40(2 Suppl):40-3. PubMed ID: 2460948
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mepartricin in the symptomatic therapy of prostatitis].
    Rocco F; Franchini V
    Minerva Urol Nefrol; 1988; 40(2 Suppl):67-9. PubMed ID: 3187842
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mepartricin in the treatment of benign prostatic hyperplasia].
    Cirillo Marucco E; Pagliarulo A; Piccinno A; Di Rienzo U
    Minerva Urol Nefrol; 1988; 40(2):101-4. PubMed ID: 2459784
    [No Abstract]   [Full Text] [Related]  

  • 18. Action of gastric and intestinal simulated juice on mepartricin stability in solid and solubilized form.
    Bruzzese T; Racchelli L; Lomi R; Rognoni S
    Farmaco Prat; 1977 Aug; 32(8):422-8. PubMed ID: 891902
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mepartricin versus placebo in the therapy of prostatic hypertrophy].
    Fini M; Perrone A; Ferraresi R; Salvi G; Misuriello G; Vagliani GF
    Minerva Urol Nefrol; 1988; 40(2 Suppl):53-4. PubMed ID: 2460953
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mepartricin in the treatment of chronic prostatitis].
    Borghi M; Cicchetti F
    Minerva Urol Nefrol; 1988; 40(2 Suppl):62-4. PubMed ID: 3187840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.